Cefpodoxime Proxetil
26 NDCs across 6 manufacturers|26 Generic,0 Brand
Cefpodoxime Proxetil is used to treat bronchitis, community-acquired infections, cystitis, escherichia coli infections, gonorrhea and haemophilus infections, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Aug 7, 1992, and the first generic was approved May 31, 2002. FDA's Orange Book lists 8 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $26 million on Cefpodoxime Proxetil across 528,000 claims for 434,000 beneficiaries.
Cefpodoxime Proxetil is available as 26 NDCs from 6 manufacturers (26 generic, 0 brand), with NADAC prices from $1.04 to $5.03 per EA — the most expensive product costs about 4.8× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
26
26G / 0B
Manufacturers
6
competing in market
Price Spread
$1.04 – $5.03
per EA, 19 of 26 NDCs
7d Activity
avg +0.2% WoW · of 26 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Aurobindo Pharma Limited manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Cephalosporin Antibacterial class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
6 manufacturers producing CEFPODOXIME PROXETIL(1 pricing outlier)
Frequently Asked Questions
What is Cefpodoxime Proxetil used to treat?
Cefpodoxime Proxetil is used to treat bronchitis, community-acquired infections, cystitis, escherichia coli infections, gonorrhea and haemophilus infections, per the National Library of Medicine's MED-RT classification.
When did Cefpodoxime Proxetil become available as a generic?
FDA approved the first generic Cefpodoxime Proxetil (ANDA) on May 31, 2002. The Orange Book currently lists 8 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Cefpodoxime Proxetil?
In 2024, Medicare Part D spent $26 million on Cefpodoxime Proxetil across 528,000 claims for 434,000 beneficiaries.
How many Cefpodoxime Proxetil products are on the market?
The Cefpodoxime Proxetil drug market contains 26 NDCs from 6 manufacturers — 26 generic and 0 brand products.
What is the price range for Cefpodoxime Proxetil?
NADAC reference prices for Cefpodoxime Proxetil range from $1.0434 to $5.0317 per EA — the most expensive product costs about 4.8× the cheapest. 7 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Which manufacturers make Cefpodoxime Proxetil?
6 manufacturers list Cefpodoxime Proxetil in NADAC. Ranked by number of NDCs, the largest are Aurobindo Pharma Limited (6), Amici Pharmaceuticals LLC (6), NorthStar Rx LLC (5), Ascend Laboratories, LLC (4), Sandoz Inc. (3).
How has the price of Cefpodoxime Proxetil changed recently?
Over the past 7 days, 10 Cefpodoxime Proxetil NDCs rose and 10 fell, with a market-wide average change of +0.2%.